FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085144919> ?p ?o ?g. }

• W2085144919 endingPage "510" @default.
• W2085144919 startingPage "501" @default.
• W2085144919 abstract "Laryngeal tumours, especially T1N0M0 and T2N0M0 lesions, are readily controlled by radiotherapy. Studies have shown that control varies with the dose of radiotherapy delivered to the tumour. Other factors, including the dose per fraction and the time over which the treatment schedule is delivered are also important. The varying biological effectiveness of a number of different dose fraction time schedules used in the management of laryngeal tumours of different stages are considered, the end points being tumour control and associated morbidity. Special attention has been given to the length of time over which the schedule is delivered. Of the schedules examined the results would suggest that a dose of 60 Gy given in 25 fractions over a period of 35 days is the best of the six schedules studied for T1, T2, T3 and T4 lesions with minimal associated morbidity. It is possible, however, that the poor results shown on the Kaplan-Meier curves for patients treated with the schedule of 60 Gy in 30 fractions over a period of 42 days could be due to geographical misses of the tumours as 56% were treated without a beam directed shell. The poor result obtained when patients were treated with the schedule of 60 Gy given in 30 fractions over 49+ days may be due to tumour repopulation occurring during the rest period though the possibility of geographical misses may contribute to the poor tumour control results. Mathematical modelling using linear quadratic analysis suggests that the shorter the period of time over which the treatment is given the better chance of achieving tumour control irrespective of the stage of the disease. These models were developed for patients treated with a beam directed shell thus excluding those patients who are most likely to be at risk from a geographic miss of the tumour. Linear quadratic analysis of the treatment data suggests that the ratio alpha/beta for tumour cells is estimated in the region of 13 Gy. For T1 lesions the tumour doubling time is in the order of 6 days, with longer doubling times for the more advanced stages. The analysis provides some support for investigative use of accelerated treatment schedules. This analysis also shows the importance of using beam directed shells when treating small fields especially in the head and neck region." @default.
• W2085144919 created "2016-06-24" @default.
• W2085144919 creator A5003860411 @default.
• W2085144919 creator A5008076402 @default.
• W2085144919 creator A5014846731 @default.
• W2085144919 creator A5033048625 @default.
• W2085144919 creator A5048853848 @default.
• W2085144919 date "1993-01-01" @default.
• W2085144919 modified "2023-10-16" @default.
• W2085144919 title "The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx" @default.
• W2085144919 cites W1971747664 @default.
• W2085144919 cites W1980020949 @default.
• W2085144919 cites W1992487094 @default.
• W2085144919 cites W1996321773 @default.
• W2085144919 cites W2000754251 @default.
• W2085144919 cites W2003502681 @default.
• W2085144919 cites W2006534438 @default.
• W2085144919 cites W2009216609 @default.
• W2085144919 cites W2013275157 @default.
• W2085144919 cites W2014809795 @default.
• W2085144919 cites W2020982398 @default.
• W2085144919 cites W2035074997 @default.
• W2085144919 cites W2050135293 @default.
• W2085144919 cites W2057408396 @default.
• W2085144919 cites W2061004798 @default.
• W2085144919 cites W2061712800 @default.
• W2085144919 cites W2075892941 @default.
• W2085144919 cites W2077470340 @default.
• W2085144919 cites W2078561021 @default.
• W2085144919 cites W2079708060 @default.
• W2085144919 cites W2084633265 @default.
• W2085144919 cites W2103094946 @default.
• W2085144919 cites W2134166601 @default.
• W2085144919 cites W2138477625 @default.
• W2085144919 cites W2289913854 @default.
• W2085144919 cites W3041047318 @default.
• W2085144919 cites W3185190045 @default.
• W2085144919 doi "https://doi.org/10.1016/s0959-8049(05)80139-x" @default.
• W2085144919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8435200" @default.
• W2085144919 hasPublicationYear "1993" @default.
• W2085144919 type Work @default.
• W2085144919 sameAs 2085144919 @default.
• W2085144919 citedByCount "49" @default.
• W2085144919 countsByYear W20851449192012 @default.
• W2085144919 countsByYear W20851449192014 @default.
• W2085144919 countsByYear W20851449192018 @default.
• W2085144919 countsByYear W20851449192019 @default.
• W2085144919 countsByYear W20851449192023 @default.
• W2085144919 crossrefType "journal-article" @default.
• W2085144919 hasAuthorship W2085144919A5003860411 @default.
• W2085144919 hasAuthorship W2085144919A5008076402 @default.
• W2085144919 hasAuthorship W2085144919A5014846731 @default.
• W2085144919 hasAuthorship W2085144919A5033048625 @default.
• W2085144919 hasAuthorship W2085144919A5048853848 @default.
• W2085144919 hasConcept C109159458 @default.
• W2085144919 hasConcept C111919701 @default.
• W2085144919 hasConcept C126322002 @default.
• W2085144919 hasConcept C141071460 @default.
• W2085144919 hasConcept C155806632 @default.
• W2085144919 hasConcept C2777546739 @default.
• W2085144919 hasConcept C2780474809 @default.
• W2085144919 hasConcept C2780918802 @default.
• W2085144919 hasConcept C2781447300 @default.
• W2085144919 hasConcept C28328180 @default.
• W2085144919 hasConcept C2908786992 @default.
• W2085144919 hasConcept C2989005 @default.
• W2085144919 hasConcept C41008148 @default.
• W2085144919 hasConcept C509974204 @default.
• W2085144919 hasConcept C54355233 @default.
• W2085144919 hasConcept C68387754 @default.
• W2085144919 hasConcept C71924100 @default.
• W2085144919 hasConcept C86803240 @default.
• W2085144919 hasConceptScore W2085144919C109159458 @default.
• W2085144919 hasConceptScore W2085144919C111919701 @default.
• W2085144919 hasConceptScore W2085144919C126322002 @default.
• W2085144919 hasConceptScore W2085144919C141071460 @default.
• W2085144919 hasConceptScore W2085144919C155806632 @default.
• W2085144919 hasConceptScore W2085144919C2777546739 @default.
• W2085144919 hasConceptScore W2085144919C2780474809 @default.
• W2085144919 hasConceptScore W2085144919C2780918802 @default.
• W2085144919 hasConceptScore W2085144919C2781447300 @default.
• W2085144919 hasConceptScore W2085144919C28328180 @default.
• W2085144919 hasConceptScore W2085144919C2908786992 @default.
• W2085144919 hasConceptScore W2085144919C2989005 @default.
• W2085144919 hasConceptScore W2085144919C41008148 @default.
• W2085144919 hasConceptScore W2085144919C509974204 @default.
• W2085144919 hasConceptScore W2085144919C54355233 @default.
• W2085144919 hasConceptScore W2085144919C68387754 @default.
• W2085144919 hasConceptScore W2085144919C71924100 @default.
• W2085144919 hasConceptScore W2085144919C86803240 @default.
• W2085144919 hasIssue "4" @default.
• W2085144919 hasLocation W20851449191 @default.
• W2085144919 hasLocation W20851449192 @default.
• W2085144919 hasOpenAccess W2085144919 @default.
• W2085144919 hasPrimaryLocation W20851449191 @default.
• W2085144919 hasRelatedWork W1637986261 @default.
• W2085144919 hasRelatedWork W2000355459 @default.
• W2085144919 hasRelatedWork W2083284378 @default.

• next